Conditional power and friends: The why and how of (un)planned, unblinded sample size recalculations in confirmatory trials
Open Access
- 13 January 2022
- journal article
- research article
- Published by Wiley in Statistics in Medicine
- Vol. 41 (5) , 877-890
Abstract
Adapting the final sample size of a trial to the evidence accruing during the trial is a natural way to address planning uncertainty. Since the sample size is usually determined by an argument based on the power of the trial, an interim analysis raises the question of how the final sample size should be determined conditional on the accrued information. To this end, we first review and compare common approaches to estimating conditional power, which is often used in heuristic sample size recalculation rules. We then discuss the connection of heuristic sample size recalculation and optimal two‐stage designs, demonstrating that the latter is the superior approach in a fully preplanned setting. Hence, unplanned design adaptations should only be conducted as reaction to trial‐external new evidence, operational needs to violate the originally chosen design, or post hoc changes in the optimality criterion but not as a reaction to trial‐internal data. We are able to show that commonly discussed sample size recalculation rules lead to paradoxical adaptations where an initially planned optimal design is not invariant under the adaptation rule even if the planning assumptions do not change. Finally, we propose two alternative ways of reacting to newly emerging trial‐external evidence in ways that are consistent with the originally planned design to avoid such inconsistencies.Keywords
All Related Versions
Funding Information
- NIHR Cambridge Biomedical Research Centre (BRC‐1215‐20014)
This publication has 20 references indexed in Scilit:
- Effect of Platelet Inhibition with Cangrelor during PCI on Ischemic EventsNew England Journal of Medicine, 2013
- Structured approach to the elicitation of expert beliefs for a Bayesian‐designed clinical trial: a case studyPharmaceutical Statistics, 2013
- Probabilistic Foundation of Confirmatory Adaptive DesignsJournal of the American Statistical Association, 2012
- An Approach to the Conditional Error Rate Principle with Nuisance ParametersBiometrics, 2010
- Optimizing Trial DesignCirculation, 2009
- The reassessment of trial perspectives from interim data—a critical viewStatistics in Medicine, 2005
- Optimal Conditional Error Functions for the Control of Conditional PowerBiometrics, 2004
- A general statistical principle for changing a design any time during the course of a trialStatistics in Medicine, 2004
- Internal pilot studies for estimating sample sizeStatistics in Medicine, 1994
- Bayesian Approaches to Randomized TrialsJournal of the Royal Statistical Society Series A: Statistics in Society, 1994